ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

August 22, 1986

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

Regulatory Agencies Get Data For Action Against One Of World’s Most Widely Used Carcinogens

October 6, 1978

SSO Education Group Lists “Major Unmet Needs, Problems”

November 25, 1983

DCE Advisors Approve New Epidemiology RFPs Table Proposed RFA

April 16, 1993

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014